[Cell cycle effects of antiestrogens and medroxyprogesterone acetate on the MCF-7 human breast cancer cell line].
D001943:Breast Neoplasms / Q000473:pathology*; D002453:Cell Cycle / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004273:DNA, Neoplasm / Q000032:analysis; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate; D009376:Neoplasms, Hormone-Dependent / Q000473:pathology*; D013629:Tamoxifen / Q000031:analogs & derivatives / Q000494:pharmacology
D004273:DNA, Neoplasm; D004965:Estrogen Antagonists; D013629:Tamoxifen; C038345:droloxifene; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone